EWS::FLI1-DHX9 interaction promotes Ewing #sarcoma sensitivity to DNA topoisomerase 1 poisons by altering R-loop metabolism
www.nature.com/articles/s41...
@grunewaldlab.bsky.social
Division of Translational Pediatric Sarcoma Research @DKFZ
EWS::FLI1-DHX9 interaction promotes Ewing #sarcoma sensitivity to DNA topoisomerase 1 poisons by altering R-loop metabolism
www.nature.com/articles/s41...
Subversion of mRNA degradation pathways by EWSR1::FLI1 represents a therapeutic vulnerability in Ewing #sarcoma
www.nature.com/articles/s41...
Der Wissenschaftliche Vorstand und Vorstandsvorsitzende, Michael Baumann (links im Bild) und der Kaufmännische Vorstand des Deutschen Krebsforschungszentrums, Ursula Weyrich, überreichten gemeinsam den DKFZ-Patienten-Experten-Preis 2025 an Rudolf Hauke. Bild: Uwe Anspach / DKFZ
Der Patienten-Experten-Preis 2025 geht an Rudolf Hauke. 👏 Mit dieser Auszeichnung würdigt das DKFZ sein langjähriges und wegweisendes Engagement für die strukturierte Beteiligung von Patient:innen in der #Krebsforschung. Herzlichen Glückwunsch! @rudolfhauke.bsky.social
t1p.de/wi4zt
Bild: DKFZ
Die Deutsche Forschungsgemeinschaft @dfg.de hat Aurélie Ernst in das Heisenberg-Programm aufgenommen, ein Förderprogramm, das sich an herausragend qualifizierte Wissenschaftler:innen richtet, die ihre Berufbarkeit auf eine Professur nachweisen können. Herzlichen Glückwunsch! 👏
16.07.2025 12:32 — 👍 8 🔁 1 💬 0 📌 0Fabricio Loayza-Puch (links) und Chong Sun Bild: DKFZ/Jung
ERC-Förderung für verbesserte Krebs-Immuntherapien: Fabricio Loayza-Puch und Chong Sun vom DKFZ erhalten schon zum zweiten Mal einen der begehrten "Proof of Concept" (PoC)-Grants. 👏
#ERCPoC @erc.europa.eu
t1p.de/4mg2g
Finally out! 🥳 Our paper showing how a transposable element (TE) insertion can cause developmental phenotypes is now published @natgenet.nature.com 🧬🦠🐁
Below is a brief description of the major findings. Check the full version of the paper for more details: www.nature.com/articles/s41588-025-02248-5
cIAP1 inhibitor of apoptosis (alias BIRC2) is a tumor suppressor in Ewing #sarcoma
www.biorxiv.org/content/10.1...
@dkfz.bsky.social
@uniheidelberg.bsky.social
@nct-heidelberg.bsky.social
Very excited to have joined the @mpi-ie.bsky.social !
Thank you for the warm welcome 🤩🤩
Congratulations to all @tum.de graduates from Freibierfest Freising - Free Beer Festival Freising 🍻 🎉 🍻
27.06.2025 17:47 — 👍 11 🔁 1 💬 0 📌 0We have several open postdoc positions! We do computational biology 🧬🖥️ and deep learning to understand the genomics of genome instability and (somatic) genome evolution in ageing and cancer. Interested? 👉🏻 more details: tu-dresden.de/cmcb/biotec/...
26.06.2025 09:46 — 👍 9 🔁 6 💬 1 📌 0🔥🔥🔥Check out our latest paper on the kidney, wonderful collaboration with Fabian Braun & Christine Kurschat @cecad.bsky.social. Read now: JCI Insight - Loss of genome maintenance is linked to mTOR complex 1 signaling and accelerates podocyte damage insight.jci.org/articles/vie...
24.06.2025 14:09 — 👍 17 🔁 8 💬 4 📌 1This work is the result of a great international collaboration!
Huge thanks to Darrell Green and Emma Bull for bringing together such a strong multidisciplinary team. Check out our review on paediatric bone sarcomas #PaedsOnc #SarcomaResearch
molecular-cancer.biomedcentral.com/articles/10....
Da die @dfg.de ja bis heute in den meisten Verfahren nur zwei Gutachten einholt, bleibt Glück ein sehr wichtiger Faktor bei Entscheidungen - unbefriedigend, seine Karriere darauf zu verwetten!
23.06.2025 12:06 — 👍 2 🔁 1 💬 0 📌 01/ Spatial transcriptomics technologies are rapidly evolving. We compared five methods—Visium, RNAscope HiPlex, Molecular Cartography, Merscope, and Xenium—and developed technology-agnostic quality control metrics to guide their use: doi.org/10.1186/s130...
20.06.2025 19:32 — 👍 16 🔁 3 💬 1 📌 2How do transcription compartments form — and does phase separation drive gene expression? I enjoyed discussing these questions with @akispapantonis.bsky.social a lot, and we put our thoughts together for @naturerevgenet.bsky.social, now out at rdcu.be/erP1u
19.06.2025 18:28 — 👍 53 🔁 14 💬 1 📌 1Martha from our lab presents her work on how EWSR1::ETS-low cells reprogram tumor metabolism to suppress NK cell activity at the #EuSARC conference in Venice
www.biorxiv.org/content/10.1...
Acquired resistance limits the efficacy of cancer treatments & accounts for therapy failure in most patients. Our Roadmap explores how innovative technologies bridge the gap between fundamental research on resistance and clinical translation into actionable strategies
www.nature.com/articles/s41...
🔬 New @natcomms.nature.com study by CeMM Adjunct PI @floriangrebien.bsky.social's team at CeMM, Vetmeduni Vienna & @stanna-ccri.bsky.social uncovers how NUP98::KDM5A drives #AML via epigenetic rewiring—identifying CDK12 as a druggable target.
➡️ More: bit.ly/3Hm6dVa
➡️ Paper: go.nature.com/3H8eCM3
💡Research team finds CDK12 is a key vulnerability in AML with NUP98 fusions. New hope for targeted therapies in resistant childhood leukemia. Study by Vetmeduni, St. Anna CCRI @floriangrebien.bsky.social & @cemm-vienna.bsky.social in Nature Communications >>> www.nature.com/articles/s41...
23.05.2025 08:34 — 👍 6 🔁 3 💬 0 📌 0Robust statistical assessment of Oncogenotype to Organotropism translation in xenografted zebrafish
www.biorxiv.org/content/10.1...
#sarcoma
Targeting metastasis in paediatric bone sarcomas
molecular-cancer.biomedcentral.com/articles/10....
Link to full text (open access) www.nature.com/articles/s41...
28.05.2025 20:47 — 👍 4 🔁 1 💬 0 📌 0Congrats, Chryssie and team!!
21.05.2025 19:00 — 👍 1 🔁 0 💬 0 📌 0EWSR1::ETS-low cells promote metabolic reprogramming of the tryptophan-kynurenine-AHR axis, immunosuppression, and poor outcome in Ewing sarcoma https://www.biorxiv.org/content/10.1101/2025.05.16.654502v1
21.05.2025 12:48 — 👍 5 🔁 3 💬 1 📌 0EWSR1::ETS-low cells promote metabolic reprogramming of the tryptophan-kynurenine-AHR axis, immunosuppression, and poor outcome in Ewing sarcoma https://www.biorxiv.org/content/10.1101/2025.05.16.654502v1
21.05.2025 12:48 — 👍 2 🔁 1 💬 0 📌 0It's been a long journey...but I finally got my board certification for Microbiology, Virology and Infection Epidemiology!
What a fun ride - thanks to all my great mentors at @healthsciences.mcgill.ca 🇨🇦 & @lmumuenchen.bsky.social 🇩🇪!
Meet the people behind #CCE! 👩🔬 Today’s spotlight is on @priyachudasama.bsky.social from @nct-heidelberg.bsky.social @dkfz.bsky.social, part of CCE’s Rare Tumors Task Force.
Discover more about her CCE journey in this interview👇
www.cancercoreeurope.eu/meet-priya-c...
🧬 New Paper out!
Kathrin Wellach and Angelika Riemer from our department published a new highly sensitive cytotoxicity assay using live-cell imaging. With this method, epitope-specific T cells can be functionally analyzed for their cytotoxic capacity!
📄 Check it out: tinyurl.com/cytotoxicity...
Not long after I started my lab, a prominent scientist told me it was “impossible” to be a successful PI and a mother
Don’t ever let the naysayers tell you it can’t be done - of course it can!
#HappyMothersDay this weekend to all the amazing scientist mamas raising their wonderful kids 🥰
Very proud on our team for winning the Gold Medal of the LEAF program for improving sustainability practices
09.05.2025 05:54 — 👍 4 🔁 1 💬 0 📌 0